Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03966404 · ClinicalTrials.gov registry record
EyeBOX Concussion Study and Registry
A clinical trial, sponsored by Oculogica.
- Completed
- Registry status
- 200
- Enrollment target
NCT03966404: Completed study, sponsored by Oculogica.
NCT03966404 is a clinical trial that has completed, run by Oculogica. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03966404 has completed, sponsored by Oculogica.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The objective of this study is to further evaluate eye movements as an aid in the diagnosis of concussion / mTBI and the utility of eye movement assessment in the monitoring of symptoms over time after an initial diagnosis of concussion.
Primary Outcome
sensitivity and specificity compared to initial clinical diagnosis of concussion
Interventions
- DIAGNOSTIC_TEST EyeBOX device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-08-05 |
| Est. Completion | 2023-06-01 |
What the finished NCT03966404 record still lists
NCT03966404 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which EyeBOX device is the first listed.
NCT03966404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03966404 about?
NCT03966404 is a clinical study titled "EyeBOX Concussion Study and Registry". The objective of this study is to further evaluate eye movements as an aid in the diagnosis of concussion / mTBI and the utility of eye movement assessment in the monitoring of symptoms over time after an initial diagnosis of concussion.
What is the current status of trial NCT03966404?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-08-05. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT03966404?
The interventions under investigation include: EyeBOX device (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03966404?
This trial is sponsored by Oculogica, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI